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Presentation of myocarditis in athletes is heterogeneous and establishing the diagnosis
is challenging with no current uniform clinical gold standard. The combined
information from symptoms, electrocardiography, laboratory testing,
echocardiography, cardiac magnetic resonance imaging, and in certain cases
endomyocardial biopsy helps to establish the diagnosis. Most patients with myocarditis
recover spontaneously; however, athletes may be at higher risk of adverse cardiac
events. Based on scarce evidence and mainly autopsy studies and expert's opinions,
current recommendations generally advise abstinence from competitive sports ranging
from a minimum of 3 to 6 months. However, the dilemma poses that (un)necessary
prolonged disqualification of athletes to avoid adverse cardiac events can cause
considerable disruption to training schedules and tournament preparation and lead to
a decline in performance and ability to compete. Therefore, better risk stratification
tools are imperatively needed. Using latest available data, this review contrasts
existing recommendations and presents a new proposed diagnostic flowchart putting a
greater focus on the use of cardiac magnetic resonance imaging in athletes with
suspected myocarditis. This may enable cardiac caregivers to counsel athletes with
suspected myocarditis more systematically and furthermore allow for pooling of more
unified data. To modify recommendations regarding sports behavior in athletes with
myocarditis, evidence, based on large multicenter registries including cardiac
magnetic resonance imaging and endomyocardial biopsy, is needed. In the future,
physicians might rely on combined novel risk stratification methods, by implementing

































Publié sur Okina (http://okina.univ-angers.fr)
